naringenin has been researched along with Diabetic Nephropathies in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kulkarni, YA; Suryavanshi, SV | 1 |
| Chen, R; Cheng, O; Ding, S; Huang, B; Huang, J; Jiang, Q; Qiu, H; Zhang, J; Zou, X | 1 |
| Ahmed, F; Banerjee, S; Roy, S; Saha, U | 1 |
| Chen, L; Duan, Q; Li, H; Liu, H; Peng, H; Peng, R; Sun, Y; Wei, L; Wen, L; Wu, T; Yan, N; Zhang, Z; Zhou, Q | 1 |
| Huang, CS; Huang, HY; Kam, WY; Mong, MC; Tsai, SJ; Yin, MC | 1 |
5 other study(ies) available for naringenin and Diabetic Nephropathies
| Article | Year |
|---|---|
Combination of Naringenin and Lisinopril Ameliorates Nephropathy in Type-1 Diabetic Rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Flavanones; Kidney; Lisinopril; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Streptozocin | 2021 |
Activation of 20-HETE/PPARs involved in reno-therapeutic effect of naringenin on diabetic nephropathy.
Topics: Animals; Cell Line; Cell Proliferation; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High-Fat; Female; Flavanones; Glucose; Hydroxyeicosatetraenoic Acids; Kidney; Mice; Peroxisome Proliferator-Activated Receptors; Rats; Streptozocin; Up-Regulation | 2019 |
Naringenin ameliorates streptozotocin-induced diabetic rat renal impairment by downregulation of TGF-β1 and IL-1 via modulation of oxidative stress correlates with decreased apoptotic events.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Flavanones; Hypoglycemic Agents; Interleukin-1; Kidney; Male; Oxidative Stress; Rats, Wistar; Signal Transduction; Streptozocin; Time Factors; Transforming Growth Factor beta1 | 2016 |
Naringenin Ameliorated Kidney Injury through Let-7a/TGFBR1 Signaling in Diabetic Nephropathy.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Flavanones; Kidney; Male; MicroRNAs; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Signal Transduction | 2016 |
Anti-inflammatory and antifibrotic effects of naringenin in diabetic mice.
Topics: Animals; Anti-Inflammatory Agents; Blood Glucose; Diabetic Nephropathies; Disease Models, Animal; Flavanones; Humans; Interleukin-6; Kidney; Male; Mice; Mice, Inbred BALB C | 2012 |